By Sabrina Bachai | Wed, 04/23/2014 - 18:13
The FDA rejected approval on a new painkiller called Moxduo, fearing it might promote more drug abuse.
By Lecia Bushak | Wed, 04/23/2014 - 18:00
In a new study, researchers have found that ghrelin, a hunger hormone, contains antidepressant properties that could lead to a new depression treatment.
By Dana Dovey | Tue, 04/22/2014 - 16:00
Two new drugs work by preventing migraines from occurring, rather than treating the condition. The results from the clinical trials have been successful so far.
By Anthony Rivas | Mon, 04/21/2014 - 17:07
Non-steroidal anti-inflammatory drugs (NSAIDs) are common painkillers for everything from arthritis to everyday pain, but they come with heart risks. Now, scientists are looking to alternative treatments.
By Susan Scutti | Mon, 04/21/2014 - 15:40
Scientists have verified a connection between colorectal cancers and dietary fats by deleting a cellular structure in mice with colon cancer.
By Jillian Rose Lim | Fri, 04/18/2014 - 17:00
Georgia Tech researchers have found a batch of counterfeit and defective drugs in their survey of contraceptives in South America.
By Lizette Borreli | Fri, 04/18/2014 - 13:10
MosKa, the "natural" libido energy drink, has been banned after Australian testers found it contained high doses of an erectile dysfunction drug.
By Sabrina Bachai | Fri, 04/18/2014 - 12:36
Marijuana still remains a criminal or civil offense in many states. Despite efforts to legalize it, opposition is still heavy.
By Susan Scutti | Thu, 04/17/2014 - 10:20
Dermatologists with access to free samples are more likely to write prescriptions for higher price tag medicines when compared to their peers who do not receive free samples.
By Chris Weller | Tue, 04/15/2014 - 17:00
Marijuana use, even casually, impairs the motivational and emotional centers of students' brains.
By Dana Dovey | Tue, 04/15/2014 - 13:20
A new report has revealed that 2013 saw a 3.2 percent increase in the amount Americans spent on medication, as compared to the previous year. The increasing figure is partly due to the high cost of specialty drugs.
By Anthony Rivas | Tue, 04/15/2014 - 12:39
The FDA's approval of Merck's Grastek ushers in a new era of grass allergy immunotherapy, as it's the second medication to be approved for grass allergies this month.